Skip to main content

Biopharma Startups

Updated October 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 906 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
906
Total Funding
$736.1M
Avg Funding
$29.4M
Global Reach
9
countries

Top Cities for Biopharma

Madison
Sandwich
South San Francisco
Philadelphia
Wellington
Boston

Recently Funded Companies

Export
Madison, United States

Axio BioPharma is a biotechnology and biomanufacturing company that provides biologics development for biopharmaceutical production.

$2.4M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Sandwich, United Kingdom

Levicept develops biological agent for the treatment of chronic pain.

$47.8M raised
Sep 2021

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Boost Biomes develops microbial products to sustainably improve food production and shelf-life.

Sep 2021

Founder Contacts

41,000+ verified contacts

Philadelphia, United States

Metabolics Pharma is a biotechnology company that offers pharmaceutical companies.

$5.5M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Wellington, New Zealand

Lucidome Bio develops a simple vaccine to reduce ruminant methane emissions while solving an acute climate change issue.

$13.5M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Boston, United States

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

$100.0M raised
Sep 2023

Founder Contacts

41,000+ verified contacts

Lexington, United States

Hyku is a biotech company that develops precise covalent targeting of disease-causing proteins.

$56.0M raised
Sep 2023

Founder Contacts

41,000+ verified contacts

Redwood City, United States

Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.

$150.0M raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Madison, United States

Stem Pharm's synthetic biomaterials support the optimization of cell expansion.

$2.5M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Staten Island, United States

GevRx Nutraceuticals is a biotechnology company currently operating in stealth mode.

$300K raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Los Angeles, United States

PictorLabs offers virtual staining technology using proprietary models powered by artificial intelligence.

$30.0M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Gainesville, United States

Kincell Bio collaborates with cell therapy developers by using considerable scientific experience and industry understanding.

$22.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Geleen, The Netherlands

Matisse Pharmaceuticals is a biopharmaceutical company developing therapies for sepsis and septic shock by targeting cytotoxic histones.

$16.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Dijon, France

AbTx is a biotech firm developing next-generation antibody-drug conjugates with enzymatic precision for oncology.

$1.9M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Ann Arbor, United States

Sling Therapeutics develops pharmaceutical treatments for thyroid eye disease, a condition that can affect tissues surrounding the eyes.

$123.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Mississauga, Canada

Launch Bioindustries is a biotechnology firm that develops sustainable biomaterials using fermentation technology.

$646K raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Blaj, Romania

Terra Wave develops fermentation process that transforms fungi-based biomass into protein rich.

$1.4M raised
Sep 2025

Founder Contacts

41,000+ verified contacts

Dortmund, Germany

KyDo Therapeutics is a biotechnology company that develops novel covalent-allosteric small molecule inhibitors.

$5.3M raised
Sep 2025

Founder Contacts

41,000+ verified contacts

Paterna, Spain

Highlight Therapeutics is a clinical-stage biopharmaceutical company.

$17.8M raised
Sep 2025

Founder Contacts

41,000+ verified contacts

Allston, United States

Elevian develops medicines that restore youthful regenerative capacity with the potential to treat and prevent many age-related diseases.

$40.0M raised
Sep 2021

Founder Contacts

41,000+ verified contacts

Reno, United States

Medical Aesthetics, Longevity, Anti-Aging, Regenerative Medicine, Wound Care, Human Collagen

$283K raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Los Angeles, United States

HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells to extend healthy lifespan.

$10.4M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Seattle, United States

HDT Bio is a developer of RNA vaccines and therapeutics based on LION formulation technology.

$5.2M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Phoenix, United States

Datavant protects, connects, and delivers the world’s health data to power better decisions and advance human health.

$40.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Emeryville, United States

RegCell develops cell therapies designed to restore immune tolerance in autoimmune diseases.

$44.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Showing 51 to 75 of 906 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 906 biopharma companies tracked in the VCBacked database.

Average Funding
$29.4M
Total Funding Tracked
$736.1M
Countries Represented
9

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Madison
2 companies$4.9M
2.Los Angeles
2 companies$40.4M
3.Sandwich
1 companies$47.8M
4.South San Francisco
1 companiesUndisclosed
5.Philadelphia
1 companies$5.5M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked